These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 28993073)

  • 1. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.
    Campbell G; Hall W; Nielsen S
    Int Rev Psychiatry; 2018 Oct; 30(5):91-106. PubMed ID: 30522342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In our war against the opioid epidemic, could 'weed' be a winner?
    Ding DD; Balkrishnan R; Diaby V
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):423-429. PubMed ID: 32799573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
    Pardo B
    Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.
    Bonar EE; Coughlin L; Roche JS; Philyaw-Kotov ML; Bixler EA; Sinelnikov S; Kolosh A; Cihak MJ; Cunningham RM; Walton MA
    Prev Med; 2020 Mar; 132():105972. PubMed ID: 31904397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Pain Clinical and Prescriptive Practices in the Cannabis Era.
    Aebischer JH; Dieckmann NF; Jones KD; St John AW
    Pain Manag Nurs; 2022 Apr; 23(2):109-121. PubMed ID: 34973920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer.
    LeBaron VT; Camacho F; Balkrishnan R; Yao NA; Gilson AM
    J Oncol Pract; 2019 Dec; 15(12):e997-e1009. PubMed ID: 31682546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.
    Coyle DT; Pratt CY; Ocran-Appiah J; Secora A; Kornegay C; Staffa J
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):464-472. PubMed ID: 29243305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
    Alcocer JJ
    Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements.
    Davis CS; Carr D
    Drug Alcohol Depend; 2016 Jun; 163():100-7. PubMed ID: 27137406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.
    Okusanya BO; Asaolu IO; Ehiri JE; Kimaru LJ; Okechukwu A; Rosales C
    Syst Rev; 2020 Jul; 9(1):167. PubMed ID: 32723354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
    Bachhuber MA; Saloner B; Cunningham CO; Barry CL
    JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):e29-49. PubMed ID: 26451760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.
    Segura LE; Mauro CM; Levy NS; Khauli N; Philbin MM; Mauro PM; Martins SS
    JAMA Netw Open; 2019 Jul; 2(7):e197216. PubMed ID: 31314118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions.
    Rigg KK; Monnat SM
    Int J Drug Policy; 2015 May; 26(5):484-91. PubMed ID: 25458403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
    Fischer B; Murphy Y; Rudzinski K; MacPherson D
    Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample.
    Schepis TS; De Nadai AS; Ford JA; McCabe SE
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e97. PubMed ID: 31992376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.